Literature DB >> 7487563

Delayed latency of the event-related brain potential P3A component in HIV disease. Progressive effects with increasing cognitive impairment.

G Fein1, C A Biggins, S MacKay.   

Abstract

OBJECTIVE: To examine the degree to which P3A latency was sensitive to the early and progressive effects of human immunodeficiency virus (HIV) disease on frontal cortex function by studying HIV-positive subjects who varied in degree of cognitive impairment.
DESIGN: Event-related brain potential studies of four groups of subjects: cognitively nonimpaired high-risk HIV-negative subjects, cognitively nonimpaired HIV-positive subjects, cognitively mildly to moderately impaired HIV-positive subjects, and cognitively severely impaired HIV-positive subjects.
SETTING: Voluntarily participating subjects on an outpatient basis at a medical center facility. PARTICIPANTS: Seventy-one community-residing gay or bisexual HIV-positive male volunteers were compared with 17 HIV-negative male gay or bisexual subjects used as a control sample. The HIV-positive subjects were stratified with regard to severity of cognitive impairment into the following three subsamples: subjects who were cognitively normal (n = 35), subjects with mild to moderate cognitive impairment (n = 20), and subjects with severe cognitive impairment (n = 16), with the samples closely matched in age. The HIV-positive subsamples were closely matched on percentage of CD4 lymphocytes. Subjects were excluded if they reported a history of drug or alcohol abuse, a major mental disorder, a head injury with loss of consciousness, or brain disease other than HIV related. MAIN OUTCOME MEASURE: P3A latency.
RESULTS: P3A latency was significantly delayed in HIV-positive subjects compared with HIV-negative control subjects, with a delay of 12 milliseconds in the cognitively normal group (P < .02) and the magnitude of delay increasing with increasing severity of HIV-associated cognitive impairments (P < .001). Delayed P3A was primarily associated with the progression of HIV-associated cognitive impairment, with a secondary and additive association with severity of HIV-associated medical illness.
CONCLUSION: This finding suggests that delayed P3A latency is sensitive to the relatively early central nervous system effects of HIV and progresses with worsening of the central nervous system effects of HIV.

Entities:  

Mesh:

Year:  1995        PMID: 7487563     DOI: 10.1001/archneur.1995.00540350103022

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  18 in total

1.  Adolescent HIV-1 transgenic rats: evidence for dopaminergic alterations in behavior and neurochemistry revealed by methamphetamine challenge.

Authors:  Landhing M Moran; Michael Y Aksenov; Rosemarie M Booze; Katy M Webb; Charles F Mactutus
Journal:  Curr HIV Res       Date:  2012-07       Impact factor: 1.581

2.  Using automated morphometry to detect associations between ERP latency and structural brain MRI in normal adults.

Authors:  Valerie A Cardenas; Linda L Chao; Rob Blumenfeld; Enmin Song; Dieter J Meyerhoff; Michael W Weiner; Colin Studholme
Journal:  Hum Brain Mapp       Date:  2005-07       Impact factor: 5.038

3.  Modeling deficits in attention, inhibition, and flexibility in HAND.

Authors:  Landhing M Moran; Rosemarie M Booze; Charles F Mactutus
Journal:  J Neuroimmune Pharmacol       Date:  2014-04-25       Impact factor: 4.147

4.  Antiviral treatment normalizes neurophysiological but not movement abnormalities in simian immunodeficiency virus-infected monkeys.

Authors:  H S Fox; M R Weed; S Huitron-Resendiz; J Baig; T F Horn; P J Dailey; N Bischofberger; S J Henriksen
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

5.  A Gap in Time: Extending our Knowledge of Temporal Processing Deficits in the HIV-1 Transgenic Rat.

Authors:  Kristen A McLaurin; Landhing M Moran; Hailong Li; Rosemarie M Booze; Charles F Mactutus
Journal:  J Neuroimmune Pharmacol       Date:  2016-10-03       Impact factor: 4.147

6.  Neurobehavioral alterations in HIV-1 transgenic rats: evidence for dopaminergic dysfunction.

Authors:  L M Moran; R M Booze; K M Webb; C F Mactutus
Journal:  Exp Neurol       Date:  2012-10-11       Impact factor: 5.330

7.  Neonatal hippocampal Tat injections: developmental effects on prepulse inhibition (PPI) of the auditory startle response.

Authors:  Sylvia Fitting; Rosemarie M Booze; Charles F Mactutus
Journal:  Int J Dev Neurosci       Date:  2006-03-13       Impact factor: 2.457

8.  Effects of heavy drinking, binge drinking, and family history of alcoholism on regional brain metabolites.

Authors:  D J Meyerhoff; R Blumenfeld; D Truran; J Lindgren; D Flenniken; V Cardenas; L L Chao; J Rothlind; C Studholme; M W Weiner
Journal:  Alcohol Clin Exp Res       Date:  2004-04       Impact factor: 3.455

9.  Prepulse inhibition in HIV-associated neurocognitive disorders.

Authors:  Arpi Minassian; Brook L Henry; Steven Paul Woods; Florin Vaida; Igor Grant; Mark A Geyer; William Perry
Journal:  J Int Neuropsychol Soc       Date:  2013-04-03       Impact factor: 2.892

10.  Mismatch negativity: no difference between controls and abstinent alcoholics.

Authors:  George Fein; Bridget Whitlow; Peter Finn
Journal:  Alcohol Clin Exp Res       Date:  2004-01       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.